Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

ClinicalTrials.gov ID: NCT03321526

Public ClinicalTrials.gov record NCT03321526. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Study identification

NCT ID
NCT03321526
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
107 participants

Conditions and interventions

Interventions

  • JNJ-42847922 Drug
  • Placebo Matching to JNJ-42847922 Drug
  • Quetiapine XR Drug
  • Placebo Matching to Quetiapine XR Drug
  • Selective Serotonin Reuptake Inhibitor (SSRI) Drug
  • Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 11, 2017
Primary completion
Jun 12, 2019
Completion
Jun 26, 2019
Last update posted
Apr 28, 2025

2017 – 2019

United States locations

U.S. sites
50
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
NoesisPharma Research Phoenix Arizona 85032
Clinical Research Consortium Arizona Tempe Arizona 85283
Woodland Research Northwest Rogers Arkansas 72758
Collaborative NeuroScience Network Garden Grove California 92845
Pacific Institute of Medical Sciences Los Angeles California 90024
National Research Institute Los Angeles California 90057
Excell Research Inc Oceanside California 92056
Desert Valley Research Rancho Mirage California 92270
Anderson Clinical Research Redlands California 92374
Artemis Institute for Clinical Research San Diego California 92103
Syrentis Clinical Research Santa Ana California 92705
Research Center for Clinical Studies, Inc. Norwalk Connecticut 06851
Clinical Research of South Florida Coral Gables Florida 33134
SIH Research Kissimmee Florida 34759
Premier Clinical Research Miami Florida 33122
Innova Clinical Trials Miami Florida 33133
Arocha Research Center Inc Miami Florida 33145
Suncoast Clinical Research New Port Richey Florida 34652
Stedman Clinical Trials Tampa Florida 33613
Northwest Behavioral Research Center Marietta Georgia 30060
Suburban Clinical Research Group, Inc Bolingbrook Illinois 60490
RxClinicals Crystal Lake Illinois 60012
Alexian Brothers Health System Hoffman Estates Illinois 60169
Psychiatric Medicine Associates LLC Skokie Illinois 60076
American Research, LLC Jeffersonville Indiana 47130
University of Iowa Iowa City Iowa 52242
Phoenix Medical Research, Inc. Prairie Village Kansas 66208
Johns Hopkins University School of Medicine Baltimore Maryland 21218
BTC of New Bedford New Bedford Massachusetts 02740
Boston Clinical Trials & Medical Research Roslindale Massachusetts 02135
Rochester Center for Behavioral Medicine (RCBM) Rochester Hills Michigan 48307
Midwest Research Group Saint Charles Missouri 63304
PsychCare Consultants Research St Louis Missouri 63128
Clinical Research Consortium Las Vegas Nevada 89119-5190
SPRI Clinical Trials, LLC Brooklyn New York 11235
CNS Research Science, Inc. Jamaica New York 11432
Hapworth Psychiatric Medical PLLC New York New York 10019
Carolina Partners c/o Tripha Life Sciences Raleigh North Carolina 27606
Patient Priority Clinical Sites LLC Cincinnati Ohio 45215
Intend Research Norman Oklahoma 73069
IPS Research Company Oklahoma City Oklahoma 73103
Sooner Clinical Research Oklahoma City Oklahoma 73112
BTC Network Lincoln Rhode Island 02865
Hawkins Psychiatry, PC Arlington Texas 76013
Baylor College of Medicine Houston Texas 77030
Houston Endoscopy and Research Center, Inc. Houston Texas 77079
Texas Center for Drug Development Inc Houston Texas 77081
Pillar Clinical Research, LLC Richardson Texas 75080
Ericksen Research and Development Clinton Utah 84015
Northwest Clinical Research Center Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03321526, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03321526 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →